共 194 条
[21]
Bagshaw SM(2022)Frontier and hotspot evolution in cardiorenal syndrome: a bibliometric analysis from 2003 to 2022 Curr Probl Cardiol 510 918-28
[22]
Bao JF(2009)Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease BMC Genom 30 658-66
[23]
Hu PP(2017)Chronic kidney disease and disproportionally increased cardiovascular damage: does oxidative stress explain the burden? Oxidative Med Cell Longev 2017 12 113-20
[24]
She QY(2019)Cardiorenal syndrome pathophysiology Cardiol Clin 78 569-76
[25]
Zhang D(2020)Cardiac biomarkers of heart failure in chronic kidney disease Clin Chim Acta 13 1372-80
[26]
Mo JJ(2019)Arterial stiffness in the heart disease of CKD J Am Soc Nephrol 36 1404-9
[27]
Li A(2022)Cardioprotection effect of Yiqi-Huoxue-Jiangzhuo formula in a chronic kidney disease mouse model associated with gut microbiota modulation and NLRP3 inflammasome inhibition Biomed Pharmacother 28 390-9
[28]
Chen CM(2019)FGF23 and phosphate-cardiovascular toxins in CKD Toxins 72 E840-E78
[29]
Hu ZG(2011)Kidney in diabetes: from organ damage target to therapeutic target Curr Drug Metab 139 undefined-undefined
[30]
Liu SB(2022)An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors Int J Mol Sci undefined undefined-undefined